Large cell lymphoma through a liquid lens-Reference-Cited by-同舟云学术

Large cell lymphoma through a liquid lens

Published:2024-05-30 Issue:1 Volume:205 Page:15-16
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shortt Jake¹²^ORCID,Opat Stephen¹²^ORCID

Affiliation:

1. Monash Haematology Monash Health Clayton Victoria Australia

2. Department of Medicine, School of Clinical Sciences at Monash Health Monash University Clayton Victoria Australia

Abstract

Liquid biopsy to provide a mutational snapshot of diffuse large B‐cell lymphoma is an emerging technology of exciting potential utility. The report by Alcoceba et al. assesses the tractability of the EuroClonality‐NDC assay to profile lymphoma using cell‐free DNA and highlights the prognostic implication of attaining a major molecular response to therapy.Commentary on: Alcoceba et al. Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease. Br J Haematol 2024;205:109–121.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19502

Reference10 articles.

1. Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease

2. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

3. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

4. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

5. Validation of the EuroClonality‐NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders;Stewart JP;Blood Adv,2021